Ross Murdoch

782 total citations · 1 hit paper
6 papers, 656 citations indexed

About

Ross Murdoch is a scholar working on Pharmacology, Oncology and Organic Chemistry. According to data from OpenAlex, Ross Murdoch has authored 6 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Ross Murdoch's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Ross Murdoch is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Ross Murdoch collaborates with scholars based in Australia, Sweden and United Kingdom. Ross Murdoch's co-authors include John Harrison, Kaj Blennow, David Ames, Ashley I. Bush, Colin L. Masters, Lars Lannfelt, Henrik Zetterberg, Craig Ritchie, Richard A. Smallwood and Hany Ghabrial and has published in prestigious journals such as The Lancet Neurology, Biochemical Pharmacology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Ross Murdoch

5 papers receiving 644 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

2008 586 citations Lars Lannfelt, Kaj Blennow et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross Murdoch Australia	5	422	217	169	112	107	6	656
Steve Macfarlane Australia	2	527 1.2×	332 1.5×	189 1.1×	159 1.4×	125 1.2×	3	811
Monica Lind Australia	9	247 0.6×	130 0.6×	47 0.3×	122 1.1×	45 0.4×	15	443
France Massicot France	17	93 0.2×	214 1.0×	109 0.6×	178 1.6×	60 0.6×	38	778
Katrin Schuessel Germany	7	450 1.1×	63 0.3×	116 0.7×	317 2.8×	28 0.3×	9	802
Takanori Hashizume Japan	18	113 0.3×	79 0.4×	104 0.6×	179 1.6×	56 0.5×	24	1.0k
Mauro Baglioni Italy	9	279 0.7×	178 0.8×	65 0.4×	142 1.3×	7 0.1×	11	570
Nakaba Murata Japan	6	248 0.6×	83 0.4×	109 0.6×	137 1.2×	21 0.2×	8	432
Osamu Cynshi Japan	20	186 0.4×	206 0.9×	77 0.5×	260 2.3×	23 0.2×	34	1.0k
Jennifer C. Schroeder United States	7	108 0.3×	33 0.2×	79 0.5×	361 3.2×	21 0.2×	8	1.1k
Deepak Bhatt United States	19	168 0.4×	24 0.1×	117 0.7×	267 2.4×	33 0.3×	31	1.0k

Countries citing papers authored by Ross Murdoch

Since Specialization

Citations

This map shows the geographic impact of Ross Murdoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Murdoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Murdoch more than expected).

Fields of papers citing papers by Ross Murdoch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Murdoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Murdoch. The network helps show where Ross Murdoch may publish in the future.

Co-authorship network of co-authors of Ross Murdoch

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Murdoch. A scholar is included among the top collaborators of Ross Murdoch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Murdoch. Ross Murdoch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Lannfelt, Lars, Kaj Blennow, Henrik Zetterberg, et al.. (2008). Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. The Lancet Neurology. 7(9). 779–786. 586 indexed citations breakdown →

2.

Conway, E. L., et al.. (1995). The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions.. British Journal of Clinical Pharmacology. 39(2). 207–209. 31 indexed citations

3.

Murdoch, Ross, et al.. (1992). Effect of malaria on phenol conjugation pathways in perfused rat liver. Biochemical Pharmacology. 43(6). 1229–1234. 11 indexed citations

4.

Ching, Michael S., et al.. (1991). Quinidine single dose pharmacokinetics and pharmacodynamics are unaltered by omeprazole. Alimentary Pharmacology & Therapeutics. 5(5). 523–531. 14 indexed citations

5.

Murdoch, Ross, Hany Ghabrial, George W. Mihaly, Denis J. Morgan, & Richard A. Smallwood. (1991). Malaria infection impairs glucuronidation and biliary excretion by the isolated perfused rat liver. Xenobiotica. 21(12). 1571–1582. 13 indexed citations

6.

Clements-Jewery, S., Colin Gardner, Saroop S. Matharu, et al.. (1988). ChemInform Abstract: (Imidazo(1,2‐a)pyrimidin‐2‐yl)phenylmethanones and Related Compounds as Potential Nonsedative Anxiolytics.. ChemInform. 19(43). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact